Flint A W J, McQuilten Z K, Wood E M
The Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Transfusion Research Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Transfus Med. 2018 Apr;28(2):140-149. doi: 10.1111/tme.12524. Epub 2018 Apr 1.
Massive transfusion or major haemorrhage protocols have been widely adopted in the treatment of critically bleeding patients. Following evidence that higher ratios of transfused plasma and platelets to red blood cells may offer survival benefits in military trauma patients, these ratios are now commonly incorporated into massive transfusion protocols. They more closely resemble the effects of whole blood transfusion, which in the second half of last century was largely replaced by individual blood component transfusion based on laboratory-guided indicators. However, high-quality evidence to guide transfusion support for critically bleeding patients across the range of bleeding contexts is lacking, including for both trauma and non-trauma patients. More data on major haemorrhage support and clinical outcomes are needed to inform guidelines and practice.
大量输血或大出血治疗方案已在严重出血患者的治疗中广泛采用。有证据表明,在军事创伤患者中,较高比例的输注血浆和血小板与红细胞可能对生存有益,目前这些比例通常已纳入大量输血治疗方案。它们更类似于全血输血的效果,而在上世纪下半叶,全血输血在很大程度上被基于实验室指导指标的单个血液成分输血所取代。然而,缺乏高质量的证据来指导在各种出血情况下对严重出血患者的输血支持,包括创伤和非创伤患者。需要更多关于大出血支持和临床结果的数据,以为指南和实践提供依据。